MARKET

EKSO

EKSO

Ekso Bionics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.26
-0.17
-2.64%
After Hours: 6.26 0 0.00% 16:00 08/07 EDT
OPEN
6.40
PREV CLOSE
6.43
HIGH
6.50
LOW
6.26
VOLUME
93.97K
TURNOVER
--
52 WEEK HIGH
13.98
52 WEEK LOW
2.250
MARKET CAP
51.78M
P/E (TTM)
-2.2310
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EKSO stock price target is 10.50 with a high estimate of 12.00 and a low estimate of 9.00.

EPS

EKSO News

More
Ekso Bionics Holdings EPS misses by $1.32, beats on revenue
Ekso Bionics Holdings (NASDAQ:EKSO): Q2 GAAP EPS of -$1.88 misses by $1.32. Revenue of $2.26M (-30.7% Y/Y) beats by $0.64M. Press Release
seekingalpha · 07/31 01:07
Ekso Bionics (EKSO) Reports Q2 Loss, Tops Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 0.00% and 22.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 07/30 23:10
Ekso Bionics Holdings Q2 EPS $(1.88) May Not Compare To $(0.55) Estimate, Sales $2.30M Beat $1.62M Estimate
Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(1.88) per share which missed the analyst consensus estimate of $(0.55) by 241.82 percent. This is a 6166.67 percent decrease over losses of $(0.03) per
Benzinga · 07/30 20:31
Ekso Bionics Reports Second Quarter 2020 Results
RICHMOND, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended June 30, 20
GlobeNewswire · 07/30 20:05
Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha · 07/30 04:00
Will Delayed Orders Hurt Ekso Bionics (EKSO) Q2 Earnings?
Ekso Bionics (EKSO) Q2 earnings are expected to have been boosted by its recent efforts to grow virtual connectivity with customers and to reduce costs.
Zacks · 07/27 15:22
Ekso Bionics® to Report Second Quarter 2020 Financial Results on July 30, 2020
RICHMOND, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quar
GlobeNewswire · 07/23 12:00
Army Distaff Foundation-Knollwood is First Life Plan Community to Adopt Ekso Bionics Exoskeleton Device for Rehabilitation Following Successful Trial
GlobeNewswire · 07/09 13:00

Industry

Advanced Medical Equipment & Technology
+0.47%
Healthcare Equipment & Supplies
+0.49%

Hot Stocks

Symbol
Price
%Change

About EKSO

Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and consumer markets. The Company operates through two segments: Engineering Services and Medical. The Engineering Services segment is engaged in collaborative research and development service arrangements, technology license agreements and government grants where it uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities, such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers and manufactures exoskeletons for applications in the medical and military markets. The Company's exoskeleton systems are worn over the user's clothing. The exoskeleton systems serve various markets, which can be used both by able-bodied users, as well as by persons with physical disabilities.
More

Webull offers kinds of Ekso Bionics Holdings Inc stock information, including NASDAQ:EKSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EKSO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EKSO stock methods without spending real money on the virtual paper trading platform.